 
                                Dr Prashanth Patel
@drprashanthpat1
Consultant Metabolic Physician, Clinical Director CSI, University Hospitals of Leicester, Hon Associate Professor, University of Leicester
ID: 914418012027056128
01-10-2017 09:13:37
34 Tweet
93 Followers
72 Following
 
         
         
         
         
         
         
        New study finds that CETP inhibitor drugs do not reduce heart disease despite increasing HDL cholesterol in part because the increase occurs in HDL subspecies that are adverse or not protective. Harvard T.H. Chan School of Public Health
 
                        
                    
                    
                    
                 
         
         
         
         
         
         
        BIG CONGRATS to our amazing boss Cathy Steele who was presented with her #Caringatitsbest Award this morning! We are all so proud of you. Thanks to @clareteeney, Matt Archer and Dr Prashanth Patel for attending also Leicester's Hospitals British Dietetic Association CN Magazine Lisa LANE
 
                        
                    
                    
                    
                 
         
         
        Ensure you’ve got your complimentary ticket for #SAHF2023 Conference. Book now via the link ➡️bitly.ws/UDIj This is not one to miss! Prof Kamlesh Khunti Prof. Wasim Hanif UHB Diabetes Diabetes UK Chaand Nagpaul Pratik Choudhary John Dennis Naaheed Mukadam Kamran Abbasi Muhammad Ali Karamat BAPIO
 
                        
                    
                    
                    
                 
         
        Prash Patel from Leicester's Hospitals now on SAHF.ORG.UK on Lipid management #SAHF2023
 
                        
                    
                    
                    
                 
        AT A GLANCE 📸-> All the Late Breaking Clinical Trials presented at #AHA2024. Yet another phenomenal year of abundant scientific education, research, and infinite hope in cardiovascular medicine.🫀 CardioNerds Amit Goyal MD MAS Daniel Ambinder, MD Naima Maqsood Sukriti Banthiya, MD
 
                        
                    
                    
                    
                 
        ![Dr Dan Goyal (@danielgoyal) on Twitter photo 3. There was a significant reduction in the rate of admissions between the non-Omicron cases and Omicron cases from October ‘21 to end Nov ‘21.  
From around 13% admission rate to the 2.5%. 
[The authors consider this most likely due to vaccine/immunity.] 3. There was a significant reduction in the rate of admissions between the non-Omicron cases and Omicron cases from October ‘21 to end Nov ‘21.  
From around 13% admission rate to the 2.5%. 
[The authors consider this most likely due to vaccine/immunity.]](https://pbs.twimg.com/media/FHLcO9vWUAQaWbQ.jpg) 
                         
                         
                         
                         
                         
                         
                        